S&P 500$7,609.78
+0.13%
2m
DOW 30$51,307.79
+0.45%
2m
NASDAQ 100$30,660.60
+0.48%
2m
Russell 2000$291.66
+0.93%
2m
Russell 1000$414.78
+0.21%
2m
S&P 400$3,754.68
+0.87%
2m
S&P 600$1,696.37
+0.88%
2m

CENTURY THERAP (IPSC)

NASDAQ

$2.07-$0.10 (-4.61%)

Price as of Jun 03, 2026 5:53 PM EDT

$441.9M
Market Cap
280.63%
1-Year Change
Biotechnology
Industry

Annual

Quarterly

	12/31/2025	12/31/2024	12/31/2023	12/31/2022
Income Statement
Total Operating Revenue	109.2M +1,556.76%	6.6M +194.81%	2.2M -57.01%	5.2M N/A
Cost of Revenue	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Gross Profit	109.2M +1,556.76%	6.6M +194.81%	2.2M -57.01%	5.2M N/A
Sales and Marketing Expense	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Research and Development Expense	-95.7M -10.80%	-107.2M +15.68%	-92.7M -13.50%	-107.2M +41.67%
Depreciation and Amortization Expense	13.1M -1.53%	13.3M +1.99%	13.0M +54.55%	8.4M +125.19%
Total Operating Expenses	126.4M -12.64%	144.7M -2.73%	148.8M +7.01%	139.0M +46.53%
Operating Profit	-17.3M -87.50%	-138.1M -5.74%	-146.5M +9.50%	-133.8M +41.05%
Interest Income	7.3M -43.52%	13.0M +2.60%	12.7M +186.81%	4.4M +1,072.41%
Interest Expense	N/A N/A	-540,000 0.00%	-540,000 -61.54%	-1.4M +10.12%
Interest Income and Expense and Net	7.3M -41.08%	12.5M +2.72%	12.1M +302.42%	3.0M +435.86%
Total Nonoperating Income and Expense	7.6M -42.96%	13.4M +13.67%	11.8M +293.11%	3.0M +432.96%
Income before Taxes	-9.6M -92.27%	-124.8M -7.43%	-134.8M +3.02%	-130.8M +36.60%
Income Taxes	-68,000 -103.80%	1.8M -4.84%	1.9M +1,967.03%	91,000 +111.63%
Extraordinary Items	6.8M -58.67%	16.4M 0.00%	16.4M N/A	N/A N/A
Net Income	-9.6M -92.43%	-126.6M -7.40%	-136.7M +4.38%	-130.9M +36.64%
Net Income from Continuing Operations Applicable to Common	-9.6M -92.27%	-124.8M -7.43%	-134.8M +3.02%	-130.8M +36.60%
Basic EPS and Net Income	-0.14 -91.30%	-1.61 -30.00%	-2.30 +1.32%	-2.27 -23.31%
Diluted EPS and Net Income	-0.14 -91.30%	-1.61 -29.07%	-2.27 0.00%	-2.27 -23.31%
Basic Weighted Average Shares	86.6M +10.05%	78.6M +32.60%	59.3M +2.70%	57.8M +78.30%
Diluted Weighted Average Shares	86.6M +10.05%	78.6M +36.17%	57.8M 0.00%	57.8M +78.30%
Balance Sheet
Cash and Cash Equivalents	61.9M +5.84%	58.4M +23.49%	47.3M -43.84%	84.3M +49.29%
Short-Term Investments	55.3M -57.77%	130.9M +4.34%	125.4M -45.76%	231.2M +38.93%
Cash and Cash Equivalents and Short-Term Investments	117.1M -38.13%	189.3M +9.58%	172.7M -45.25%	315.5M +41.56%
Total Current Assets	120.8M -37.76%	194.1M +9.64%	177.0M -44.64%	319.7M +40.13%
Accumulated Depreciation	48.6M +34.78%	36.1M +57.89%	22.8M +67.25%	13.7M +156.24%
Property and Plant and Equipment and Net	50.0M -19.50%	62.1M -13.34%	71.7M -13.38%	82.8M +42.81%
Total Long-Term Assets	50.0M -19.50%	62.1M -13.34%	71.7M -13.38%	82.8M +42.81%
Total Assets	223.7M -36.67%	353.2M -2.07%	360.7M -25.87%	486.5M +11.24%
Income Taxes Payable	4.3M -1.67%	4.4M -57.89%	10.4M -8.10%	11.3M +53.32%
Total Short-Term Debt	N/A N/A	N/A N/A	6.5M 0.00%	6.5M +525.79%
Total Current Liabilities	20.2M -84.42%	129.8M +627.23%	17.8M -40.15%	29.8M +90.46%
Total Long-Term Debt	N/A N/A	N/A N/A	3.7M 0.00%	3.7M -58.00%
Total Long-Term Liabilities	48.8M -71.11%	169.1M +4.52%	161.8M +5.55%	153.3M +553.27%
Total Liabilities	64.8M -66.24%	191.9M +9.04%	175.9M -4.28%	183.8M +346.81%
Retained Earnings	-791.9M +1.22%	-782.3M +19.30%	-655.8M +26.33%	-519.1M +33.73%
Total Stockholders Equity	158.9M -1.50%	161.4M -12.66%	184.8M -38.97%	302.7M -23.60%
Total Shares Outstanding	87.5M +1.96%	85.8M +42.26%	60.3M +9.69%	55.0M 0.00%
Cash Flow
Cash from Operating Activities	-103.9M -5.68%	-110.1M +24.66%	-88.3M -728.72%	14.1M +115.79%
Capital Expenditures	848,000 +450.65%	154,000 -98.88%	13.7M -55.12%	30.6M -31.95%
Cash from Investing Activities	107.5M +126.40%	47.5M -22.33%	61.1M +565.66%	-13.1M -95.60%
Dividends Paid	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Cash from Financing Activities	173,000 -99.77%	74.6M +866.71%	-9.7M -135.81%	27.2M -93.50%
Financials Ratio
Gross Margin	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Operating Margin	-15.82% -99.25%	-2,096.48% -68.03%	-6,556.87% +154.72%	-2,574.17% N/A
Return on Assets	-3.32% -90.63%	-35.46% +9.90%	-32.26% +13.83%	-28.34% N/A
Return on Equity	-5.98% -91.82%	-73.14% +30.43%	-56.07% +49.67%	-37.46% N/A
Revenue Growth	1,556.76% +699.12%	194.81% +441.71%	-57.01% N/A	N/A N/A
Current Ratio	5.97 +299.34%	1.50 -84.92%	9.92 -7.51%	10.72 N/A
Cash Ratio	3.06 +579.13%	0.45 -83.02%	2.65 -6.17%	2.83 N/A
Debt-to-Equity Ratio	N/A N/A	N/A N/A	0.06 +63.91%	0.03 N/A
Debt-to-Assets Ratio	N/A N/A	N/A N/A	0.03 +35.24%	0.02 N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow